Stay updated on Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has removed detailed information about a clinical study evaluating the safety and efficacy of Bermekimab for moderate to severe atopic dermatitis, while adding a new identifier and a revision number.SummaryDifference26%
- Check33 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 4, 2025.SummaryDifference0.2%
- Check41 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 4, 2025, and version 2.14.2.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check91 days agoChange DetectedThe webpage has been updated to reflect new clinical research organizations and a new estimated last update date, while also noting that some services are experiencing heavy traffic, which may impact performance.SummaryDifference1%
Stay in the know with updates to Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.